Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 7/2011

01.10.2011 | Original Article

Surgery for liver metastases originating from sarcoma—case series

verfasst von: Maximilian Zacherl, Gerwin A. Bernhardt, Johannes Zacherl, Gerald Gruber, Peter Kornprat, Heinz Bacher, Hans-Jörg Mischinger, Reinhard Windhager, Raimund Jakesz, Thomas Grünberger

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 7/2011

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Liver metastases originating from various types of sarcoma are a rare reason for hepatic resection. So far, even multicentre studies do hardly provide statistically relevant sample sizes. Thus, review of available data can provide surgeons with useful information in similar cases. Therefore, this study can be regarded more as a contribution to this pool of data than as a stand-alone paper.

Patients and methods

The study includes 10 women and five men who underwent subtotal hepatic resection for solitary (n = 4) and multiple (n = 11) liver metastases originating from sarcoma. The median tumour diameter was 60 mm (range 20–200 mm).

Results

Morbidity was 33%. One patient died within 30 days after surgery. Resection was complete (R0) in 67%. Median overall survival was 33.6 months, 5-year survival 27%. The use of Pringle manoeuvre was significantly associated with poorer outcome (p = 0.014) and shorter period of recurrence-free survival (p = 0.012). Diameter of liver lesion over 50 mm showed significantly shorter recurrence-free survival (p = 0.042).

Conclusion

Hepatic resection may be beneficial in patients with isolated sarcoma metastasis in the liver.
Literatur
1.
Zurück zum Zitat Van Glabbeke M, van Oosterom AT, Oosterhuis JW et al (1999) Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens—a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol 17(1):150–157PubMed Van Glabbeke M, van Oosterom AT, Oosterhuis JW et al (1999) Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens—a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol 17(1):150–157PubMed
2.
Zurück zum Zitat Billingsley KG, Burt ME, Jara E et al (1999) Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg 229(5):602–610, discussion 610–612PubMedCrossRef Billingsley KG, Burt ME, Jara E et al (1999) Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg 229(5):602–610, discussion 610–612PubMedCrossRef
3.
Zurück zum Zitat Smith R, Pak Y, Kraybill W, Kane JM 3rd (2009) Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy. Eur J Surg Oncol 35(4):356–361PubMed Smith R, Pak Y, Kraybill W, Kane JM 3rd (2009) Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy. Eur J Surg Oncol 35(4):356–361PubMed
4.
Zurück zum Zitat Jain A, Sajeevan KV, Babu KG, Lakshmaiah KC (2009) Chemotherapy in adult soft tissue sarcoma. Indian J Cancer 46(4):274–287PubMedCrossRef Jain A, Sajeevan KV, Babu KG, Lakshmaiah KC (2009) Chemotherapy in adult soft tissue sarcoma. Indian J Cancer 46(4):274–287PubMedCrossRef
5.
Zurück zum Zitat Chen H, Pruitt A, Nicol TL et al (1998) Complete hepatic resection of metastases from leiomyosarcoma prolongs survival. J Gastrointest Surg 2(2):151–155PubMedCrossRef Chen H, Pruitt A, Nicol TL et al (1998) Complete hepatic resection of metastases from leiomyosarcoma prolongs survival. J Gastrointest Surg 2(2):151–155PubMedCrossRef
6.
Zurück zum Zitat Elias D, Cavalcantide de Albuquerque A, Eggenspieler P et al (1998) Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg 187(5):487–493PubMedCrossRef Elias D, Cavalcantide de Albuquerque A, Eggenspieler P et al (1998) Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg 187(5):487–493PubMedCrossRef
7.
Zurück zum Zitat Hemming AW, Sielaff TD, Gallinger S et al (2000) Hepatic resection of noncolorectal nonneuroendocrine metastases. Liver Transpl 6(1):97–101PubMed Hemming AW, Sielaff TD, Gallinger S et al (2000) Hepatic resection of noncolorectal nonneuroendocrine metastases. Liver Transpl 6(1):97–101PubMed
8.
Zurück zum Zitat Jaques DP, Coit DG, Casper ES, Brennan MF (1995) Hepatic metastases from soft-tissue sarcoma. Ann Surg 221(4):392–397PubMedCrossRef Jaques DP, Coit DG, Casper ES, Brennan MF (1995) Hepatic metastases from soft-tissue sarcoma. Ann Surg 221(4):392–397PubMedCrossRef
9.
Zurück zum Zitat Lang H, Nussbaum KT, Kaudel P et al (2000) Hepatic metastases from leiomyosarcoma: a single-center experience with 34 liver resections during a 15-year period. Ann Surg 231(4):500–505PubMedCrossRef Lang H, Nussbaum KT, Kaudel P et al (2000) Hepatic metastases from leiomyosarcoma: a single-center experience with 34 liver resections during a 15-year period. Ann Surg 231(4):500–505PubMedCrossRef
10.
Zurück zum Zitat Morrow CE, Grage TB, Sutherland DE, Najarian JS (1982) Hepatic resection for secondary neoplasms. Surgery 92(4):610–614PubMed Morrow CE, Grage TB, Sutherland DE, Najarian JS (1982) Hepatic resection for secondary neoplasms. Surgery 92(4):610–614PubMed
11.
Zurück zum Zitat O’Rourke TR, Tekkis P, Yeung S et al (2008) Long-term results of liver resection for non-colorectal, non-neuroendocrine metastases. Ann Surg Oncol 15(1):207–218PubMedCrossRef O’Rourke TR, Tekkis P, Yeung S et al (2008) Long-term results of liver resection for non-colorectal, non-neuroendocrine metastases. Ann Surg Oncol 15(1):207–218PubMedCrossRef
12.
Zurück zum Zitat Zacherl M, Langle F, Steininger R et al (2001) Surgery for non-colorectal and non-neuroendocrine liver metastases. Wien Klin Wochenschr 113(17–18):681–687PubMed Zacherl M, Langle F, Steininger R et al (2001) Surgery for non-colorectal and non-neuroendocrine liver metastases. Wien Klin Wochenschr 113(17–18):681–687PubMed
13.
Zurück zum Zitat Zacherl J, Zacherl M, Scheuba C et al (2002) Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointest Surg 6(5):682–689PubMedCrossRef Zacherl J, Zacherl M, Scheuba C et al (2002) Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointest Surg 6(5):682–689PubMedCrossRef
14.
Zurück zum Zitat DeMatteo RP, Shah A, Fong Y et al (2001) Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 234(4):540–547, discussion 547–548PubMedCrossRef DeMatteo RP, Shah A, Fong Y et al (2001) Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 234(4):540–547, discussion 547–548PubMedCrossRef
15.
Zurück zum Zitat Adam R, Chiche L, Aloia T et al (2006) Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg 244(4):524–535PubMed Adam R, Chiche L, Aloia T et al (2006) Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg 244(4):524–535PubMed
16.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213PubMedCrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213PubMedCrossRef
17.
Zurück zum Zitat Pringle JHV (1908) Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 48(4):541–549PubMedCrossRef Pringle JHV (1908) Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 48(4):541–549PubMedCrossRef
18.
Zurück zum Zitat Pawlik TM, Vauthey JN, Abdalla EK et al (2006) Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg 14(6):537–543, discussion 543–544 Pawlik TM, Vauthey JN, Abdalla EK et al (2006) Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg 14(6):537–543, discussion 543–544
19.
Zurück zum Zitat Zalinski S, Palavecino M, Abdalla EK (2009) Hepatic resection for gastrointestinal stromal tumor liver metastases. Hematol Oncol Clin North Am 23(1):115–127, ixPubMedCrossRef Zalinski S, Palavecino M, Abdalla EK (2009) Hepatic resection for gastrointestinal stromal tumor liver metastases. Hematol Oncol Clin North Am 23(1):115–127, ixPubMedCrossRef
20.
Zurück zum Zitat Yap BS, Baker LH, Sinkovics JG et al (1980) Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas. Cancer Treat Rep 64(1):93–98PubMed Yap BS, Baker LH, Sinkovics JG et al (1980) Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas. Cancer Treat Rep 64(1):93–98PubMed
21.
Zurück zum Zitat Ng EH, Pollock RE, Romsdahl MM (1992) Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas. Cancer 69(6):1334–1341PubMedCrossRef Ng EH, Pollock RE, Romsdahl MM (1992) Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas. Cancer 69(6):1334–1341PubMedCrossRef
22.
Zurück zum Zitat Verazin GT, Warneke JA, Driscoll DL et al (1992) Resection of lung metastases from soft-tissue sarcomas. A multivariate analysis. Arch Surg 127(12):1407–1411PubMed Verazin GT, Warneke JA, Driscoll DL et al (1992) Resection of lung metastases from soft-tissue sarcomas. A multivariate analysis. Arch Surg 127(12):1407–1411PubMed
23.
Zurück zum Zitat Ercolani G, Grazi GL, Ravaioli M et al (2005) The role of liver resections for noncolorectal, nonneuroendocrine metastases: experience with 142 observed cases. Ann Surg Oncol 12(6):459–466PubMedCrossRef Ercolani G, Grazi GL, Ravaioli M et al (2005) The role of liver resections for noncolorectal, nonneuroendocrine metastases: experience with 142 observed cases. Ann Surg Oncol 12(6):459–466PubMedCrossRef
24.
Zurück zum Zitat Reddy SK, Barbas AS, Marroquin CE et al (2007) Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis. J Am Coll Surg 204(3):372–382PubMedCrossRef Reddy SK, Barbas AS, Marroquin CE et al (2007) Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis. J Am Coll Surg 204(3):372–382PubMedCrossRef
25.
Zurück zum Zitat Rehders A, Peiper M, Stoecklein NH et al (2009) Hepatic metastasectomy for soft-tissue sarcomas: is it justified? World J Surg 33(1):111–117PubMedCrossRef Rehders A, Peiper M, Stoecklein NH et al (2009) Hepatic metastasectomy for soft-tissue sarcomas: is it justified? World J Surg 33(1):111–117PubMedCrossRef
26.
Zurück zum Zitat Mavligit GM, Zukwiski AA, Ellis LM et al (1995) Gastrointestinal leiomyosarcoma metastatic to the liver. Durable tumor regression by hepatic chemoembolization infusion with cisplatin and vinblastine. Cancer 75(8):2083–2088PubMedCrossRef Mavligit GM, Zukwiski AA, Ellis LM et al (1995) Gastrointestinal leiomyosarcoma metastatic to the liver. Durable tumor regression by hepatic chemoembolization infusion with cisplatin and vinblastine. Cancer 75(8):2083–2088PubMedCrossRef
27.
Zurück zum Zitat Demetri GD, von Mehren M, Blanke CD et al (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347(7):472–480PubMedCrossRef Demetri GD, von Mehren M, Blanke CD et al (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347(7):472–480PubMedCrossRef
28.
Zurück zum Zitat DeMatteo RP, Ballman KV, Antonescu CR et al (2009) Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet 373(9669):1097–1104PubMedCrossRef DeMatteo RP, Ballman KV, Antonescu CR et al (2009) Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet 373(9669):1097–1104PubMedCrossRef
29.
Zurück zum Zitat DeMatteo RP, Maki RG, Singer S et al (2007) Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor. Ann Surg 245(3):347–352PubMedCrossRef DeMatteo RP, Maki RG, Singer S et al (2007) Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor. Ann Surg 245(3):347–352PubMedCrossRef
30.
Zurück zum Zitat Bernhard GA, Bacher H, Hagen D et al (2004) Heat shock protein 70: a new biomarker for ischemic–reperfusion injury due to Pringle maneuver. Eur Surg 36(5):305–310CrossRef Bernhard GA, Bacher H, Hagen D et al (2004) Heat shock protein 70: a new biomarker for ischemic–reperfusion injury due to Pringle maneuver. Eur Surg 36(5):305–310CrossRef
31.
Zurück zum Zitat El-Badry AM, Breitenstein S, Jochum W et al (2009) Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 250(5):691–697PubMedCrossRef El-Badry AM, Breitenstein S, Jochum W et al (2009) Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 250(5):691–697PubMedCrossRef
32.
Zurück zum Zitat Earle SA, Perez EA, Gutierrez JC et al (2006) Hepatectomy enables prolonged survival in select patients with isolated noncolorectal liver metastasis. J Am Coll Surg 203(4):436–446PubMedCrossRef Earle SA, Perez EA, Gutierrez JC et al (2006) Hepatectomy enables prolonged survival in select patients with isolated noncolorectal liver metastasis. J Am Coll Surg 203(4):436–446PubMedCrossRef
33.
Zurück zum Zitat Goering JD, Mahvi DM, Niederhuber JE et al (2002) Cryoablation and liver resection for noncolorectal liver metastases. Am J Surg 183(4):384–389PubMedCrossRef Goering JD, Mahvi DM, Niederhuber JE et al (2002) Cryoablation and liver resection for noncolorectal liver metastases. Am J Surg 183(4):384–389PubMedCrossRef
34.
Zurück zum Zitat Harrison LE, Brennan MF, Newman E et al (1997) Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery 121(6):625–632PubMedCrossRef Harrison LE, Brennan MF, Newman E et al (1997) Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery 121(6):625–632PubMedCrossRef
35.
Zurück zum Zitat Lendoire J, Moro M, Andriani O et al (2007) Liver resection for non-colorectal, non-neuroendocrine metastases: analysis of a multicenter study from Argentina. HPB (Oxford) 9(6):435–439 Lendoire J, Moro M, Andriani O et al (2007) Liver resection for non-colorectal, non-neuroendocrine metastases: analysis of a multicenter study from Argentina. HPB (Oxford) 9(6):435–439
36.
Zurück zum Zitat van Ruth S, Mutsaerts E, Zoetmulder FA, van Coevorden F (2001) Metastasectomy for liver metastases of non-colorectal primaries. Eur J Surg Oncol 27(7):662–667PubMed van Ruth S, Mutsaerts E, Zoetmulder FA, van Coevorden F (2001) Metastasectomy for liver metastases of non-colorectal primaries. Eur J Surg Oncol 27(7):662–667PubMed
37.
Zurück zum Zitat Yedibela S, Gohl J, Graz V et al (2005) Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review. Ann Surg Oncol 12(10):778–785PubMedCrossRef Yedibela S, Gohl J, Graz V et al (2005) Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review. Ann Surg Oncol 12(10):778–785PubMedCrossRef
38.
Zurück zum Zitat Foster JH (1978) Survival after liver resection for secondary tumors. Am J Surg 135(3):389–394PubMedCrossRef Foster JH (1978) Survival after liver resection for secondary tumors. Am J Surg 135(3):389–394PubMedCrossRef
39.
Zurück zum Zitat Teo MC, Tan YM, Chung AY et al (2006) Metastectomy for non-colorectal, non-neuroendocrine liver secondaries. ANZ J Surg 76(7):575–578PubMedCrossRef Teo MC, Tan YM, Chung AY et al (2006) Metastectomy for non-colorectal, non-neuroendocrine liver secondaries. ANZ J Surg 76(7):575–578PubMedCrossRef
Metadaten
Titel
Surgery for liver metastases originating from sarcoma—case series
verfasst von
Maximilian Zacherl
Gerwin A. Bernhardt
Johannes Zacherl
Gerald Gruber
Peter Kornprat
Heinz Bacher
Hans-Jörg Mischinger
Reinhard Windhager
Raimund Jakesz
Thomas Grünberger
Publikationsdatum
01.10.2011
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 7/2011
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-011-0821-8

Weitere Artikel der Ausgabe 7/2011

Langenbeck's Archives of Surgery 7/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.